Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic

Edwards Lifesciences received FDA clearance for its left atrial appendage (LAA) clip device, creating new competition in the LAA closure market against AtriCure and Medtronic. The company plans a measured rollout of the device to existing surgical heart valve customers.